I am buying back next week if it’s stay cheaper, look like a strong buying opportunity at present for long holding or short with its price-to-sales ratio of 5.3x, considering almost half of all companies in the Biotechs industry in the United States have P/S ratios greater than 13.7x and even P/S higher than 69x aren't out of the ordinary.
Don't consider selling before profitability, page-336
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
